drugset
drugset / Trial / NCT00518271

Study Comparing Standard Dose and Reduced Dose Tacrolimus + Sirolimus + Corticosteroids in Renal Allograft Recipients

NCT00518271 ↗

Phase 2 Completed 120 enrolled Wyeth is now a wholly owned subsidiary of Pfizer
RandomizedParallel-groupOpen-labelTreatment

Summary

This study evaluated renal graft function based on calculated creatinine clearance at 6 months after transplantation in patients receiving a regimen of 'reduced' or 'standard' dose tacrolimus plus sirolimus and corticosteroids.

Timeline

Start
2000-04
Primary completion
—
Completion
2002-06

Drugs

EvaluationDrugModalityDoseRoute
Subject Tacrolimus Small molecule — —
Background Sirolimus Small molecule — —

Indications

No indication recorded.